# Early vs Late Introduction of Antiretroviral Therapy in HIV-infected Patients With Tuberculosis (ANRS 1295 CAMELIA)

> **NCT00226434** · PHASE3 · COMPLETED · sponsor: **French National Agency for Research on AIDS and Viral Hepatitis** · enrollment: 661 (actual)

## Conditions studied

- HIV Infection
- Tuberculosis

## Interventions

- **PROCEDURE:** Early antiretroviral treatment
- **PROCEDURE:** Late antiretroviral treatment

## Key facts

- **NCT ID:** NCT00226434
- **Lead sponsor:** French National Agency for Research on AIDS and Viral Hepatitis
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-01
- **Primary completion:** 2010-05
- **Final completion:** 2010-05
- **Target enrollment:** 661 (ACTUAL)
- **Last updated:** 2012-03-16

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00226434

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00226434, "Early vs Late Introduction of Antiretroviral Therapy in HIV-infected Patients With Tuberculosis (ANRS 1295 CAMELIA)". Retrieved via AI Analytics 2026-07-25 from https://api.ai-analytics.org/clinical/NCT00226434. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*